Literature DB >> 6220624

Pancuronium, unlike other nondepolarizing relaxants, retains potency at hypothermia.

J C Horrow, R R Bartkowski.   

Abstract

The authors studied the pharmacodynamics of four nondepolarising relaxants, d-tubocurarine (dTC), pancuronium, metocurine, and gallamine, at 25 degrees C, 31 degrees C, and 37 degrees C. The rat phrenic nerve-hemidiaphragm preparation with vascular perfusion was used for these investigations. For each drug at each temperature, a dose-response curve for twitch depression was constructed. ED50 values were calculated using probit-log dose regression. dTC, metocurine, and gallamine each demonstrated a near twofold increase in ED50 at 25 degrees C compared with 37 degrees C. No such relationship was apparent with pancuronium. In addition, the slopes of the dose-response curves were analyzed for effects due to temperature or drug. Slopes were not influenced by temperature; however, the slopes for metocurine and dTC were lower than those for pancuronium and gallamine. The authors conclude that in the rat, pancuronium retains potency at hypothermia, whereas the other relaxants decrease potency. In addition, metocurine and dTC exhibit less steep dose-response curves under these experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6220624     DOI: 10.1097/00000542-198304000-00010

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  2 in total

Review 1.  Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies.

Authors:  Marcel P H van den Broek; Floris Groenendaal; Antoine C G Egberts; Carin M A Rademaker
Journal:  Clin Pharmacokinet       Date:  2010-05       Impact factor: 6.447

2.  The effects of temperature on the interactions between volatile general anaesthetics and a neuronal nicotinic acetylcholine receptor.

Authors:  R Dickinson; W R Lieb; N P Franks
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.